SEC – ‘UPLOAD’ from 6/22/22 re: HealthySole Inc. – ‘TEXT-EXTRACT’

On:  Wednesday, 6/22/22, at 3:30pm ET   ·   Delayed-Release:  Filing ¶  –  Release Delayed   ·   Accession #:  0-22-6726

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Comment or Other Letter from the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: LETTER      Comment or Other Letter from the SEC                 PDF     38K 
 2: TEXT-EXTRACT  Comment or Other Letter from the SEC - PDF's         1      5K 
                Text                                                             

‘TEXT-EXTRACT’   —   Comment or Other Letter from the SEC – PDF’s Text

United States securities and exchange commission logo                           

June 22, 2022         

Peter Kassel                                                      
Chief Executive Officer                                           
HealthySole Inc                                                   
774 Mays Blvd. #10-220                                            
Incline Village, NV 89451                                         

                                                   Re: HealthySole Inc
                                                          Offering Statement
on Form 1-A                                                                     
                                                           Filed June 16, 2022
                                                          File No. 024-11909

Dear Mr. Kassel:                                                  

                                                     This is to advise you
that we do not intend to review your offering statement.                        

         We will consider qualifying your offering statement at your
request. If a participant in                                                    
   your offering is required to clear its compensation arrangements with
FINRA, please have                                                              
FINRA advise us that it has no objections to the compensation     
arrangements prior to                                                           
qualification.                                                    

   We remind you that the company and its management are
responsible for the accuracy                                                    
      and adequacy of their disclosures, notwithstanding any review, comments,
action or absence of                                                            
      action by the staff. We also remind you that, following qualification of
your Form 1-A, Rule 257                                                         
of Regulation A requires you to file periodic and current reports,
including a Form 1-K which                                                      
   will be due within 120 calendar days after the end of the fiscal year
covered by the report.                                                          

                                              Please contact
Christine Westbrook at 202-551-5019 with any questions.                         

Sincerely,            

         Division of Corporation Finance

 Office of Life Sciences
    cc:                                              Nicholas Antaki, Esq.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘UPLOAD’ Filing		Date		Other Filings
Filed on:		6/22/22		UPLOAD
		6/16/22		1-A,  UPLOAD
				List all Filings